Even in small villages with a population of less than 1,000, where certain remedies including cough syrups were allowed to be sold without ...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Pregabalin, a nerve pain medication, now faces stricter controls. The Union health ministry has moved it to Schedule H1. This change aims t...

India's beauty industry is emerging as a global force, blending Ayurvedic heritage with modern science to create "I-beauty." With rising ex...

Ajanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra...

India's drug regulator, the DCGI, is set to meet with cosmetics industry representatives to address regulatory concerns. The industry seeks...

China's cosmetics industry is booming as consumers splurge on personal care products amid the pandemic. However, foreign cosmetics companie...

The apex public policy think tank of the central government also suggested creating a separate authority to regulate medical devices in the...

The CDSCO and Ministry of Health have taken regulatory measures to ensure the quality of medicines in the country as part of which the Drug...

"The aim is to build trust and confidence on the quality of Indian drugs, cosmetics and medical devices in the domestic and global markets."

India is yet to move away from understanding drug regulation as purely a manufacturing issue to a public health one. Technically, the quali...

The panel will conduct consultations and examine the present Act, previously framed drugs and cosmetics bills and submit a draft document b...

The government is planning an overhaul of the country’s drug regulatory body. Towards this, the committee has recommended introduction of c...

Previously, licensed manufacturers of drugs and medical devices could export them only to the US, Canada, Japan, Australia and the European...

Medical devices industry has the potential to touch USD 30 billion mark in the next ten years if proper regulatory framework is provided.

The government should set up a dedicated authority for dealing with issues related to medical devices, industry chamber FICCI said today.